Article info
PDFResearch ethics
Paper
Unrealistic optimism and the ethics of phase I cancer research
- Correspondence to Dr Eric Kodish, Center for Ethics, Humanities, and Spiritual Care, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA; kodishe{at}ccf.org
Citation
Unrealistic optimism and the ethics of phase I cancer research
Publication history
- Received April 26, 2012
- Revised September 10, 2012
- Accepted September 25, 2012
- First published October 31, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Two concepts of therapeutic optimism
- Phase 1 oncology trials and informed consent
- Understanding people’s ‘unrealistic optimism’ about clinical research participation
- Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
- Perceptions of control and unrealistic optimism in early-phase cancer trials
- Faith, Hope And (No) Clarity
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis
- Can phase I cancer research studies in children be justified on ethical grounds?
- Phase I cancer trials: a qualitative study of specialist palliative care
- Is best interests a relevant decision making standard for enrolling non-capacitated subjects into clinical research?